{"id":"https://openalex.org/W4403537633","doi":"https://doi.org/10.1016/j.esmoop.2024.103759","title":"13P Methylation of BRCA1 and RAD51C promoters determined by droplet digital PCR predicts homologous repair deficiency in patients with high-grade serous ovarian cancer: Results of the BOVARY-pilot study in paired FFPE and plasma samples and the ICL ovarian cohort","display_name":"13P Methylation of BRCA1 and RAD51C promoters determined by droplet digital PCR predicts homologous repair deficiency in patients with high-grade serous ovarian cancer: Results of the BOVARY-pilot study in paired FFPE and plasma samples and the ICL ovarian cohort","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403537633","doi":"https://doi.org/10.1016/j.esmoop.2024.103759"},"language":"en","primary_location":{"id":"doi:10.1016/j.esmoop.2024.103759","doi":"https://doi.org/10.1016/j.esmoop.2024.103759","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2024.103759","pdf_url":"https://www.esmoopen.com/article/S2059-7029(24)01529-1/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.esmoopen.com/article/S2059-7029(24)01529-1/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112083728","display_name":"Cassandra Michel","orcid":"https://orcid.org/0009-0005-8986-698X","observed_orcids":["https://orcid.org/0009-0005-8986-698X"]},"institutions":[{"id":"https://openalex.org/I4210099203","display_name":"Institut de Canc\u00e9rologie de Lorraine","ror":"https://ror.org/00yphhr71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099203"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Michel","raw_affiliation_strings":["D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210099203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023920977","display_name":"Andr\u00e9a Witz","orcid":"https://orcid.org/0000-0002-1131-5193","observed_orcids":["https://orcid.org/0000-0002-1131-5193"]},"institutions":[{"id":"https://openalex.org/I4210099203","display_name":"Institut de Canc\u00e9rologie de Lorraine","ror":"https://ror.org/00yphhr71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099203"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Witz","raw_affiliation_strings":["D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210099203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092960735","display_name":"Idrissia Hanriot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100260","display_name":"Centre Hospitalier R\u00e9gional et Universitaire de Nancy","ror":"https://ror.org/016ncsr12","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100260"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"I. Hanriot","raw_affiliation_strings":["D\u00e9partement de Biopathologie, CHRU Nancy, Vandoeuvre-L\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie, CHRU Nancy, Vandoeuvre-L\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210100260"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024232075","display_name":"Julie Dardare","orcid":"https://orcid.org/0000-0002-5315-1852","observed_orcids":["https://orcid.org/0000-0002-5315-1852"]},"institutions":[{"id":"https://openalex.org/I4210099203","display_name":"Institut de Canc\u00e9rologie de Lorraine","ror":"https://ror.org/00yphhr71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099203"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. Dardare","raw_affiliation_strings":["D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210099203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028236670","display_name":"Margaux Betz","orcid":"https://orcid.org/0009-0003-2090-6918","observed_orcids":["https://orcid.org/0009-0003-2090-6918"]},"institutions":[{"id":"https://openalex.org/I4210099203","display_name":"Institut de Canc\u00e9rologie de Lorraine","ror":"https://ror.org/00yphhr71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099203"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Betz","raw_affiliation_strings":["D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210099203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054181755","display_name":"Marie Rouyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099203","display_name":"Institut de Canc\u00e9rologie de Lorraine","ror":"https://ror.org/00yphhr71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099203"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Rouyer","raw_affiliation_strings":["D\u00e9partement de Biopathologie, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210099203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107413616","display_name":"Marie Husson","orcid":"https://orcid.org/0000-0002-9338-9822","observed_orcids":["https://orcid.org/0000-0002-9338-9822"]},"institutions":[{"id":"https://openalex.org/I4210099203","display_name":"Institut de Canc\u00e9rologie de Lorraine","ror":"https://ror.org/00yphhr71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099203"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Husson","raw_affiliation_strings":["D\u00e9partement de Biopathologie, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210099203"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Brun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100260","display_name":"Centre Hospitalier R\u00e9gional et Universitaire de Nancy","ror":"https://ror.org/016ncsr12","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100260"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Brun","raw_affiliation_strings":["D\u00e9partement de Biopathologie, CHRU Nancy, Vandoeuvre-L\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie, CHRU Nancy, Vandoeuvre-L\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210100260"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Lefebvre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099203","display_name":"Institut de Canc\u00e9rologie de Lorraine","ror":"https://ror.org/00yphhr71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099203"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Lefebvre","raw_affiliation_strings":["D\u00e9partement de Biopathologie, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210099203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015888185","display_name":"C\u00e9line Gavoille","orcid":"https://orcid.org/0009-0008-1648-3023","observed_orcids":["https://orcid.org/0009-0008-1648-3023"]},"institutions":[{"id":"https://openalex.org/I4210099203","display_name":"Institut de Canc\u00e9rologie de Lorraine","ror":"https://ror.org/00yphhr71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099203"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Gavoille","raw_affiliation_strings":["D\u00e9partement d'Oncologie M\u00e9dicale, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement d'Oncologie M\u00e9dicale, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210099203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052908696","display_name":"Pauline Gilson","orcid":"https://orcid.org/0000-0001-6735-563X","observed_orcids":["https://orcid.org/0000-0001-6735-563X"]},"institutions":[{"id":"https://openalex.org/I4210099203","display_name":"Institut de Canc\u00e9rologie de Lorraine","ror":"https://ror.org/00yphhr71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099203"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Gilson","raw_affiliation_strings":["D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210099203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028755998","display_name":"J.L. Merlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099203","display_name":"Institut de Canc\u00e9rologie de Lorraine","ror":"https://ror.org/00yphhr71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099203"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J.L. Merlin","raw_affiliation_strings":["D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210099203"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003880256","display_name":"Alexandre Harl\u00e9","orcid":"https://orcid.org/0000-0001-9548-6522","observed_orcids":["https://orcid.org/0000-0001-9548-6522"]},"institutions":[{"id":"https://openalex.org/I4210099203","display_name":"Institut de Canc\u00e9rologie de Lorraine","ror":"https://ror.org/00yphhr71","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210099203"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"A. Harl\u00e9","raw_affiliation_strings":["D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement de Biopathologie - Service de Biologie Mol\u00e9culaire des Tumeurs, Institut de Canc\u00e9rologie de Lorraine - Alexis Vautrin, Vandoeuvre-l\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I4210099203"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3730,"currency":"USD","value_usd":3730},"apc_paid":{"value":3730,"currency":"USD","value_usd":3730},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"9","issue":null,"first_page":"103759","last_page":"103759"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.7378000020980835,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.7378000020980835,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.19339999556541443,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.05900000035762787,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brca1-promoter-methylation","display_name":"BRCA1 promoter methylation","score":0.9010000228881836},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9419999718666077},{"id":"https://openalex.org/keywords/high-grade-serous-ovarian-carcinoma","display_name":"high-grade serous ovarian cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/droplet-digital-pcr","display_name":"droplet digital PCR","score":0.8820000290870667},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.574999988079071},{"id":"https://openalex.org/keywords/epigenetic-silencing","display_name":"epigenetic silencing","score":0.6830000281333923},{"id":"https://openalex.org/keywords/brca-mutations","display_name":"BRCA mutations","score":0.7549999952316284},{"id":"https://openalex.org/keywords/plasma-dna","display_name":"plasma DNA","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.6977289915084839},{"id":"https://openalex.org/C2993684365","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Serous ovarian cancer","level":4,"score":0.614719033241272},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5699622631072998},{"id":"https://openalex.org/C101762097","wikidata":"https://www.wikidata.org/wiki/Q224093","display_name":"Promoter","level":4,"score":0.5536912083625793},{"id":"https://openalex.org/C48126324","wikidata":"https://www.wikidata.org/wiki/Q5276136","display_name":"Digital polymerase chain reaction","level":4,"score":0.48261985182762146},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.4796760082244873},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4756162762641907},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45720726251602173},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44016069173812866},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3443698287010193},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2935425043106079},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2613758444786072},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.20986050367355347},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20978397130966187},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.20742130279541016},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.esmoop.2024.103759","doi":"https://doi.org/10.1016/j.esmoop.2024.103759","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2024.103759","pdf_url":"https://www.esmoopen.com/article/S2059-7029(24)01529-1/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.esmoop.2024.103759","doi":"https://doi.org/10.1016/j.esmoop.2024.103759","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2024.103759","pdf_url":"https://www.esmoopen.com/article/S2059-7029(24)01529-1/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403537633.pdf","grobid_xml":"https://content.openalex.org/works/W4403537633.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400983447","https://openalex.org/W4295226724","https://openalex.org/W4366082786","https://openalex.org/W4392374985","https://openalex.org/W3116222145","https://openalex.org/W2623527064","https://openalex.org/W4413042476","https://openalex.org/W4387825554","https://openalex.org/W1973188720","https://openalex.org/W4200524965"],"abstract_inverted_index":{"Ovarian":[0],"cancer":[1],"(OC)":[2],"stands":[3],"as":[4],"the":[5,16],"ninth":[6],"leading":[7],"cause":[8],"of":[9,37,54,62,91],"cancer-related":[10],"deaths":[11],"in":[12,57],"women":[13],"and":[14,40,81,89],"represents":[15],"most":[17],"prevalent":[18],"gynaecological":[19],"malignancy.":[20],"Patients":[21],"with":[22],"OC":[23],"are":[24,70,85],"more":[25],"likely":[26],"to":[27,59,72],"benefit":[28],"from":[29],"iPARP":[30],"if":[31,41],"their":[32],"tumours":[33],"present":[34],"deleterious":[35,52],"mutations":[36,53],"BRCA1/2":[38,55],"genes,":[39],"they":[42],"have":[43,77],"a":[44],"homologous":[45],"recombination":[46],"deficiency":[47],"(HRD).":[48],"Somatic":[49],"or":[50],"germline":[51],"occurs":[56],"15":[58],"20":[60],"%":[61],"HRD":[63,68,92],"OC.":[64],"However,":[65],"not":[66],"all":[67],"cases":[69],"due":[71],"these":[73],"mutations.":[74],"Indeed,":[75],"studies":[76],"shown":[78],"that":[79],"BRCA1":[80],"RAD51C":[82],"promoter":[83],"methylation":[84],"responsible":[86],"for":[87],"19%":[88],"2%":[90],"cases,":[93],"respectively.":[94]},"counts_by_year":[],"updated_date":"2026-10-11T09:32:39.932853","created_date":"2024-10-19T00:00:00"}